CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) [Phase 2]
Summary
A Phase 2 study of MK0431 in Type 2 diabetes mellitus has completed. The update notes the status of the trial but does not include results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type II | Phase 2 | Status: COMPLETED